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Background: Depression in later life is a common mental disorder with a prevalence rate of between 3% and 35%
for minor depression and approximately 2% for Major Depressive Disorder (MDD). The most common treatment
modalities for MDD are antidepressant medication and psychological interventions. Recently, Behavioral Activation
(BA) has gained renewed attention as an effective treatment modality in MDD. Although BA is considered an easy
accessible intervention for both patients and health care workers (such as nurses), there is no research on the
effectiveness of the intervention in inpatient depressed elderly.
The aim of study, described in the present proposal, is to examine the effects of BA when executed by nurses in an
inpatient population of elderly persons with MDD.
Methods/design: The study is designed as a multi-center cluster randomized controlled trial. BA, described as The
Systematic Activation Method (SAM) will be compared with Treatment as Usual (TAU). We aim to include ten
mental health care units in the Netherlands that will each participate as a control unit or an experimental unit. The
patients will meet the following criteria: (1) a primary diagnosis of Major Depressive Disorder (MDD) according to
the DSM-IV criteria; (2) 60 years or older; (3) able to read and write in Dutch; (4) have consented to participate via
the informed consent procedure. Based on an effect size d = 0.7, we intend to include 51 participants per condition
(n = 102). The SAM will be implemented within the experimental units as an adjunctive therapy to Treatment As
Usual (TAU). All patients will be assessed at baseline, after eight weeks, and after six months. The primary outcome
will be the level of depression measured by means of the Beck Depression Inventory (Dutch version). Other
assessments will be activity level, mastery, costs, anxiety and quality of life.
Discussion: To our knowledge this is the first study to test the effect of Behavioral Activation as a nursing
intervention in an inpatient elderly population. This research has been approved by the medical research ethics
committee for health-care settings in the Netherlands (No. NL26878.029.09) and is listed in the Dutch Trial Register
(NTR No.1809).
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Depression in later life is a common mental disorder.
Prevalence rates for depressive symptoms range between
3% and 35%, for minor depression approximately 10%
[1], and for Major Depressive Disorder (MDD) 2% [2].
The prognosis of MDD in later life is poor: in three
quarters of cases, the disorder becomes chronic [3].
MDD has serious consequences for everyday life (e.g.
withdrawal from social activities, neglect of one’s self-
care), with a risk of increased health care consumption
[4,5]. MDD has one of the largest disease burdens, com-
parable with other chronic diseases such as diabetes or
COPD. About one third of patients with MDD will be
referred to a mental health care facility (ambulatory or
residential) [5]. The elderly are particularly at risk of
developing persistent MDD because of their vulnerabil-
ity to physical illnesses, which may contribute to the
onset and persistence of MDD [6].
The most common treatment modalities for MDD are
antidepressant medication and psychological interven-
tions (or a combination thereof ) [7]. Antidepressants
seem to be efficacious in treating late-life depression, al-
though the treatment outcomes may be less positive for
the subpopulation of older elderly [8]. There are several
psychotherapeutic options in depression treatment.
Among adults in general, these different options are
comparable in their effectiveness [9]. Recently, Behav-
ioral Activation (BA) has gained renewed attention as an
effective treatment modality in MDD. In BA, patients
learn techniques to monitor their mood and daily activ-
ities and to gain insights into the connection between
the two. The patients then learn how to develop a plan
that increases the number of pleasant activities and posi-
tive interactions with their environment. A meta-analysis
has demonstrated large effect sizes for BA interventions
(d = 0.89) when compared to a waiting list condition
[10]. Furthermore, direct comparisons between Cogni-
tive Therapy (CT) and BA have demonstrated that the
effectiveness of the two interventions is comparable
[11,12]. Since BA seems to be more accessible for many
patients than CT, BA might be a preferred treatment op-
tion. Another meta-analysis shows that, in general, psy-
chotherapy seems to be as effective for older individuals
as for younger adults [9]. However, this meta-analysis
did not include studies focusing on severely depressed
or hospitalized patients. In general, psychological treat-
ments have been found to be less effective in outpatients
with chronic depression [13], and possibly severe depres-
sion [14], although the evidence is not conclusive [15].
Inpatient treatment remains an important treatment
option for patients who cannot safely stay in their own
environment [16]. Many of these patients suffer from se-
vere and chronic forms of depression, and effective treat-
ment options are needed to improve their recovery andreduce their suffering. The number of studies on psycho-
logical treatment for inpatients is limited. Recently, we
summarized those studies in a meta-analysis and
demonstrated small but robust effects [17]. However,
there was a considerable variation in treatment setting,
content of treatment, number of sessions, and inclusion
and exclusion criteria applied. Furthermore, the quality
of most of the studies was not optimal.
To our knowledge, there is only one study in which
BA is tested in an inpatient population [18]. In this
study, a total of 25 inpatient depressed adults were allo-
cated either to BA (N= 10) or to Supportive Psychother-
apy (SP) (N= 15). Despite the small sample, the study
demonstrated the effectiveness of BA, with an effect size
of 0.73. It is noteworthy that in this study, BA was exe-
cuted by clinicians who had Master’s degrees, although
BA is supposed to be an intervention which requires no
complex skills.
The aim of study described in the present proposal is
to examine the effects of BA when executed by nurses
(RNs) in an inpatient population of elderly people with
MDD. In this study, BA takes the form of a brief behav-
ioral course of treatment lasting seven weeks, known as
the Systematic Activation Method (SAM).
Methods/design
Study design
The study is designed as a multi-center cluster rando-
mized controlled trial with the participation of ten men-
tal health-care facilities in the Netherlands. The
Systematic Activation Method (SAM) will be compared
with Treatment As Usual (TAU) for inpatient depressed
elderly. In Figure 1 the study design is summerized.
The study has been approved by the medical research
ethics committee for health-care settings in the Nether-
lands (No. NL26878.029.09) and is listed in the Dutch
Trial Register (NTR No. 1809).
The units and randomization
The study will include ten mental health care units,
which will be randomized to the experimental (SAM) or
control (TAU) conditions. The following inclusion cri-
teria will be used to select the units: (1) the units must
specialize in the treatment of elderly patients with psy-
chiatric disorders; (2) there must be at least three regis-
tered nurses (RNs) available who are able and willing to
execute the intervention. Units that specialize in a spe-
cific disorder or treatment method (e.g. Electro Convul-
sion Therapy) will be excluded from the study.
Within each mental health institute, the aim is to find
two units which are comparable. Matching of units is
based on two criteria which will be applied in the follow-
ing order: (1) level of restraint – both units should either
be open or closed; (2) the presence of other treatments
Units (n=5) performing the 
intervention. 
Number of patients per unit: 
10 (or 11).
Exclusion:
-patient declines to 
participate
Allocation to experimental  
condition (TAU + SAM):
-MDD (according to the MINI)
-MMSE ≥ 23
- Written informed consent
-Reads and writes in Dutch
Randomization at unit level.
Allocation to control 
condition (TAU):
-MDD (according to the MINI)
-MMSE ≥ 23
-Written informed consent
-Reads and writes in Dutch
Assessing eligibility of all  
patients admitted.
Units (n=5) performing the 
intervention. 
Number of patients per unit: 
10 (or 11).
Follow-up:
-8 weeks after baseline
-6 months after baseline
Follow-up:
-8 weeks after baseline
-6 months after baseline
Analysis (n=51). Analysis (n=51).
Figure 1 Flowchart.
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apy (because it focuses on activation), psychological
treatment (because it focuses on influencing cognition).
For matching purposes, staff members at the partici-
pating units will be asked to fill in a self-developed
evaluation form providing information on the specific
features of the unit. This form includes a number of
general questions concerning characteristics of the pa-
tient group, followed by more specific questions about
the treatment program and level of restraint.
After matching the units into pairs, one unit will be
allocated to the experimental condition and the other tothe control condition. Allocation will be performed by
an independent researcher (AvS) who will not maintain
contact with the participating units. A random allocation
generator will be used.
Inclusion and exclusion criteria
The following patient inclusion criteria will be applied:
(1) a primary diagnosis of Major Depressive Disorder
(MDD) according to the DSM-IV criteria [19]. Patients
with multiple diagnoses (e.g. comorbid personality dis-
order) are eligible as long as the primary diagnosis is
MDD; (2) 60 years or older; (3) able to read and write in
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tion via the informed consent procedure.
Patients with severe cognitive problems (see below)
will be excluded from this study because the interven-
tion requires cognitive skills such as planning and evalu-
ating activities and the structured monitoring of mood
state.Recruitment of the study sample
The participating units will keep a list of all newly ad-
mitted patients and their primary diagnosis. All patients
older than 60 with a primary diagnosis of MDD will be
approached by a staff member and informed about the
study. Once verbal consent is obtained and there are no
cognitive problems according to the Minimal Mental
State Examination (MMSE score ≥ 23) [20], the patients
will be approached by one of the researchers. Confirm-
ation of the psychiatric diagnosis will be executed by
means of a diagnostic interview using the MINI Plus, a
standardized instrument to assess psychiatric disorders
according to the DSM-IV criteria [21]. Patients who sat-
isfy the inclusion criteria will then be included in the
study. Due to the nature of the intervention, it will not
be possible to perform the study as either a single-blind
or double-blind trial.Intervention
We developed the Systematic Activation Method (SAM)
as a brief behavioral nursing intervention which focuses
on increasing a positive mood change by increasing the
number of positive activities. The SAM is based on Be-
havioral Activation (BA), developed by Lewinsohn and
colleagues [22-27] and Hopko et al. [18]. The underlying
assumption is that positive reinforcement of a low re-
sponse rate acts as an eliciting stimulus for depressive
behaviors and serves as a sufficient explanation for in-
activity in a depressed individual [27]. The SAM is pre-
sented as a brief seven-week course. In order to make
the SAM accessible for the elderly inpatient population,
we have made some adjustments to the existing BA pro-
tocols. First, the goals of each session are described in
the course book. This differs from the existing protocols,
in which the first session is used for mutual goal setting.
It is difficult to describe the overall goals of treatment
for inpatient elderly with MDD; that is why the goals
have been described at the beginning of each session.
Second, the course is presented as a nursing interven-
tion instead of a psychological intervention in order to
increase its accessibility. Third, we simplified the activity
logs to avoid overloading the patients. Fourth, the dur-
ation of the intervention has been shortened to seven
weeks, in contrast to the existing treatment protocols,
which last between eight and 15 weeks.The SAM consists of six sequential steps: 1) monitor-
ing the patient’s mood; 2) having the patient execute
pleasant activities, randomly selected from an existing
list of 49 activities [25]; 3) having the patient develop a
positive activity plan; 4) having the patient explore how
to use external resources; 5) setting up an activity ex-
periment; 6) evaluation and consolidation. There is a
one-week time interval for each step except the third
step (developing a positive activity plan), for which two
one-week intervals are required. If necessary, the time
interval between the sessions can be reduced or extend.
Each session is highly structured and starts with a review
of the patient’s homework. After that, the nurse and pa-
tient discuss the central theme of the session and the pa-
tient is given his or her homework assignments for the
coming week. The SAM is described in more detail by
Clignet, Van Meijel, Van Straten, Lampe and Cuijpers
[28].
The SAM requires the patient’s active involvement.
This is often difficult due to the nature of MDD. The
nurses participating in this study will therefore be given
a brief training course of two four-hour sessions on
guiding patients in executing the SAM. Training consists
of two components. First, the nurses will be taught the
structure and process of the SAM. Second, they will be
trained in using motivational techniques. Many patients
with MDD have difficulty engaging in structured activ-
ities, this being one of the essential components of the
SAM. The use of motivational techniques is therefore
vital for the effective execution of the SAM.
During the study, the participating nurses will receive
training on the job, with the researcher visiting the units
for in biweekly supervision meetings. In addition, the re-
searcher will maintain telephone and e-mail contact.
During the supervision meetings, the nurses will be
invited to reflect on their experiences during execution
of the SAM intervention and – in the event of problem-
atic implementation – adjustments and alternative strat-
egies can be discussed. The biweekly meetings will
therefore be used to establish treatment integrity, along
with a random audit of the course books and a written
evaluation by the patients in order to register the
received components of the SAM intervention.
The participating patients will receive the SAM as an
individual adjunctive therapy combined with their exist-
ing primary treatment.
Control group
The control group will receive Treatment As Usual
(TAU). The most common treatment for patients with
MDD is a combination of medication, occupational ther-
apy and a form of psychological treatment such as Cog-
nitive Behavioral Therapy (CBT) or Problem Solving
Treatment (PST). Nursing care focuses on assisting
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them to participate in the unit’s daily activity program.
Nurses also discuss the patient’s overall progress on a
regular basis (weekly or biweekly). TAU is recorded at
unit level. Before participating in the study, the units de-
scribe their treatment program for MDD using a struc-
tured form developed by the authors. This form is based
on the NICE standard for MDD [7] and the Dutch
guideline for MDD [29].
Assessment
All patients will be assessed at baseline, after eight
weeks, and after six months. Each assessment will in-
volve patients filling in a questionnaire. At baseline, we
will collect demographic data (gender, social status, edu-
cation, and ethnicity) and some information about the
disease history (former episodes of MDD, frequency and
nature of former treatments [outpatient treatments and/
or clinical admittance], and psychiatric co-morbidity).
Primary outcome
Our primary outcome is the level of depression. This is
measured by means of the Beck Depression Inventory,
second edition (BDI-II-NL) [30,31]. The BDI-II is a self-
report scale which contains 21 items clustered in four
response categories. The BDI-II is divided into two com-
ponents, an affective component (e.g. mood) and a phys-
ical component (e.g. loss of appetite). The cut off scores
are: 0 – 13 for minimal depression, 14 – 19 for mild de-
pression, 20 – 28 for moderate depression, and 29 – 63
for severe depression. The Dutch version of the BDI-II
has a high internal consistency (Chronbach’s α ≥ 0.90)
and a strong correlation with other depression instru-
ments [32].
Secondary outcome
Secondary outcomes are: level of activity, anxiety, mas-
tery, quality of life, costs and health care use.
An Activity Log (AL) will be used to measure the level
of activity. This is a form in which the patient fills in hisTable 1 Overview of instruments





Mastery: Pearlin Mastery Scale X
Anxiety: HADS-A X
Quality of life: SF-36 X
Health care costs: TiC-P X
Activity Log Xor her activities over the past week. The AL contains a
week schedule which is divided into morning, afternoon
and evening activities. The patients will be asked to fill
in the activities they have executed during the past week
at baseline and after six months. The number of activ-
ities and the type of activity will be used to calculate the
activity level of each patient.
The seven anxiety items of the HADS (Hospital Anx-
iety Depression Scale) [33] will be used to measure anx-
iety. A four-point Likert scale is used to score the items
(0 – 3) and the total score therefore ranges from 0 (no
anxiety) to 21 (very anxious). The cut-off score is ≥ 8, as
an indication for an Anxiety Disorder.
Mastery will be measured by means of the Pearlin
Mastery Scale [34]. This is a five-item self-report scale
measuring internal locus of control. The items are pre-
sented as statements to be scored on a five-point Likert
scale. The scores on the Pearlin Mastery Scale range
from 5 (minimum level of mastery) to 25 (maximum
level of mastery).
Quality of life will be measured by means of the SF 36
(MOS Short Forms Health Survey) [35]. The scale con-
tains 36 questions divided into eight subscales with three
underlying dimensions: (1) Functional Status: physical
functioning (10 questions), social functioning (2 ques-
tions), role functioning – physical problems (4 ques-
tions), role functioning – emotional problems (3
questions); (2) Welfare: mental health (5 questions),
vitality (4 questions), pain (2 questions); (3) Evaluation
of health care: general health perception (5 questions),
change in health care (1 question). The response
options vary from dichotomous to a six-point Likert
scale. The SF-36 was translated into Dutch by
Van der Zee & Sanderman [36].
Costs will be measured by means of the TiC-P (Trim-
bos/iMTA questionnaire for costs associated with Psy-
chiatric Illness) [37]. This questionnaire consists of two
parts: direct costs of care consumption and indirect
costs of care consumption. The TiC-P is a broad ques-







Clignet et al. BMC Psychiatry 2012, 12:144 Page 6 of 8
http://www.biomedcentral.com/1471-244X/12/144population. This study will make use of the categories
‘care consumption’, ‘informal care consumption’, and ‘use
of medication’. All items have dichotomous ‘yes/no’ re-
sponse options. The questionnaire will be completed by
the patient as a self-report instrument.
Table 1 provides an overview of the instruments.
Statistical analyses
The primary outcome is level of depression as measured
with the BDI-II-NL. This outcome will be used to test
the effect of the SAM as a nursing intervention in in-
patient depressed elderly compared with TAU. The SAM
is considered effective if there is a significant decrease in
the level of depression in the treatment group compared
to the control group. Because the patients will be rando-
mized at unit level, multi-level analyses will be used to
test the effects of the SAM intervention. In order to in-
vestigate differences in demographic and clinical vari-
ables, ANOVAs and Chi-square tests will be executed.
Differences between the two groups in baseline charac-
teristics will be corrected where necessary. For patient-
oriented outcomes, Clinical Significant Change will be
used [38,39].
Data will be analyzed according to the ‘intention-to-
treat’ principle as well as the ‘completers only’ principle.
In order to correct for missing values, Last Observa-
tion Carried Forward and Multiple Imputation will be
used as a sensitivity analysis.
Secondary outcome variables are quality of life (SF-
36), costs (TiC-P), level of mastery (Pearlin Mastery
Scale) and activities (Activity Log).
Anxiety is considered a co-variable because of its close
association with MDD.
Sample size
Effect sizes (d) will be used to calculate the sample size.
A meta-analysis by Cuijpers et al. [10] found an overall
effect size of d = 0.87 in favor of Behavioral Activation
(BA) compared to a waiting list condition. A study in an
inpatient population found an effect size of d = 0.73 in
favor of BA compared to supportive therapy [18].
Our study will be performed in an inpatient elderly
population with severe MDD. Because of the large effect
sizes in previous studies, an effect size of d = 0.7 is
expected. With α= 0.05 and a power (1-β) of 0.8, 34
patients are needed per condition. In other studies
[10,40], the dropout rate shows a large variability (2% –
50%). For this study, we assume an average drop-out rate
of 25%. Another rule of the thumb is to increase the
study population by 25% when patients are randomized
at unit level. That means that 51 patients are required
for each condition. In total, 102 patients will be included
in this study. The sample size was calculated using the
G*power 3.0 software program [41].Discussion
This study will test Behavioral Activation (BA) as a nurs-
ing intervention in an inpatient elderly population. The
study is innovative in two aspects. First, in previous
studies psychologists with Master’s degrees carried out
this intervention [10,11,18]. In our study, BA has been
adapted to make it a nursing intervention – the SAM –
to be carried out by registered nurses [28]. This makes
BA more accessible for a larger group of patients.
Second, to our knowledge, most of the research on BA
has mainly been conducted in outpatient adult popula-
tions. Only one other study [18] was executed in an in-
patient adult population (N= 25) and, as far as we are
aware, there are no studies in elderly inpatient popula-
tions. Studies in the elderly population are relatively
scarce and have focused on outpatients [42,43] or de-
pression in combination with dementia [44,45]. To our
knowledge, this is the first BA effect study in an elderly
inpatient population worldwide.
In addition to the innovative nature of this study, there
are some difficulties concerning the study design. First,
the study is vulnerable to selection bias. The SAM will
be implemented in five mental health care units, and
decisions regarding patient inclusion will depend par-
tially on the anticipated efforts of the staff nurses. In
order to minimize selection bias, the researcher will
make an initial selection of eligible patients. Despite this,
however, selection bias cannot be ruled out entirely, be-
cause it is ultimately the nurse who must motivate the
patient to participate in the study, and this is expected
to depend on the nurses’ belief that the SAM will be
helpful for the patient. This may lead to selection bias in
the experimental group, while the selection of patients
in the control group will probably be free of bias. We
will correct for any differences between the two groups
in our statistical procedures.
This study will furthermore be vulnerable to informa-
tion bias because a blind trial at intervention level is not
possible. In order to avoid information bias, only self-
report scales will be used in this study.
Finally, the standardized execution of the intervention
is a point of concern. The SAM will be implemented at
five units for elderly persons with psychiatric disorders.
Although the SAM is presented as a highly prescriptive
intervention, we expect that – due to differences in pa-
tient characteristics – individual variations in the execu-
tion of the SAM may occur that will be difficult for the
researchers to control. Coaching meetings will be orga-
nized to promote treatment integrity.
Ethical considerations
In the experimental condition, the SAM will be imple-
mented as an adjunctive treatment modality. This means
that patients with MDD will have an opportunity to
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usual. Although the study is intended for a broad cat-
egory of patients, some patients will be excluded from
the study, even though the nurses believe they could
benefit from the SAM or parts thereof. These patients
will also have an opportunity to engage in the SAM, but
they will not be included in the study.
The SAM will be implemented in the control group
units after all the patients have been included.
Trial status
The research is ongoing at the moment. We estimate
that data-gathering will be completed in October 2012.
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